113 related articles for article (PubMed ID: 19156864)
1. Immunoadsorption with tryptophan columns: a therapeutic option for the treatment of rheumatoid arthritis with septic complications.
Thomaidis T; Schorn C; Flaig W; Lingg G; Schönhals E; Klingel R; Galle PR; Schwarting A
J Clin Apher; 2009; 24(1):37-41. PubMed ID: 19156864
[TBL] [Abstract][Full Text] [Related]
2. Treatment of patients with refractory rheumatoid arthritis with extracorporeal protein A immunoadsorption columns: a pilot trial.
Wiesenhutter CW; Irish BL; Bertram JH
J Rheumatol; 1994 May; 21(5):804-12. PubMed ID: 8064718
[TBL] [Abstract][Full Text] [Related]
3. Plasma exchange for rheumatoid arthritis.
Seror R; Pagnoux C; Guillevin L
Transfus Apher Sci; 2007 Apr; 36(2):195-9. PubMed ID: 17499763
[TBL] [Abstract][Full Text] [Related]
4. Clinical improvement in a patient with severe rheumatoid arthritis and chronic hepatitis B after prosorba column immunoadsorption: a one-year followup.
Mugnier B; Poullin P; Lefevre P; Roudier J
Arthritis Rheum; 2003 Oct; 49(5):722-3. PubMed ID: 14558061
[No Abstract] [Full Text] [Related]
5. [Long-term treatment of refractory myasthenia gravis with immunoadsorption].
Wagner S; Janzen RW; Mohs C; Pohlmann S; Klingel R; Grützmacher PW
Dtsch Med Wochenschr; 2008 Nov; 133(46):2377-82. PubMed ID: 18988129
[TBL] [Abstract][Full Text] [Related]
6. Extracorporeal immunoadsorption treatment for rheumatoid arthritis.
Hailey D; Topfer LA
Issues Emerg Health Technol; 2002 Jan; (28):1-4. PubMed ID: 11968222
[TBL] [Abstract][Full Text] [Related]
7. Plasma adiponectin in patients with active, early, and chronic rheumatoid arthritis who are steroid- and disease-modifying antirheumatic drug-naive compared with patients with osteoarthritis and controls.
Laurberg TB; Frystyk J; Ellingsen T; Hansen IT; Jørgensen A; Tarp U; Hetland ML; Hørslev-Petersen K; Hornung N; Poulsen JH; Flyvbjerg A; Stengaard-Pedersen K
J Rheumatol; 2009 Sep; 36(9):1885-91. PubMed ID: 19684150
[TBL] [Abstract][Full Text] [Related]
8. Linear IgA disease: successful application of immunoadsorption and review of the literature.
Kasperkiewicz M; Meier M; Zillikens D; Schmidt E
Dermatology; 2010; 220(3):259-63. PubMed ID: 20130384
[TBL] [Abstract][Full Text] [Related]
9. Patients with moderate rheumatoid arthritis (RA) achieve better disease activity states with etanercept treatment than patients with severe RA.
Keystone E; Freundlich B; Schiff M; Li J; Hooper M
J Rheumatol; 2009 Mar; 36(3):522-31. PubMed ID: 19228659
[TBL] [Abstract][Full Text] [Related]
10. Acute glomerulonephritis occurring during immunoadsorption with staphylococcal protein A column (Prosorba).
Iglesias J; D'Agati VD; Levine JS
Nephrol Dial Transplant; 2004 Dec; 19(12):3155-9. PubMed ID: 15575004
[TBL] [Abstract][Full Text] [Related]
11. Protein A immunoadsorption therapy for refractory, mitomycin C-associated thrombotic microangiopathy.
Kasper S; Neurath MF; Huber C; Theobald M; Scharrer I
Transfusion; 2007 Jul; 47(7):1263-7. PubMed ID: 17581162
[TBL] [Abstract][Full Text] [Related]
12. Vasculitis secondary to staphylococcal Protein A immunoadsorption (Prosorba column) treatment in rheumatoid arthritis.
Deodhar A; Allen E; Daoud K; Wahba I
Semin Arthritis Rheum; 2002 Aug; 32(1):3-9. PubMed ID: 12219317
[TBL] [Abstract][Full Text] [Related]
13. Successful therapy of pemphigus vulgaris with immunoadsorption using the TheraSorb adsorber.
Günther C; Laske J; Frind A; Julius U; Pfeiffer C
J Dtsch Dermatol Ges; 2008 Aug; 6(8):661-3. PubMed ID: 18371053
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of rheumatoid arthritis.
Sokka T
Curr Opin Rheumatol; 2009 May; 21(3):284-90. PubMed ID: 19342954
[TBL] [Abstract][Full Text] [Related]
15. Guillain-Barré syndrome treated by membrane plasma exchange and/or immunoadsorption.
Marn Pernat A; Buturović-Ponikvar J; Svigelj V; Ponikvar R
Ther Apher Dial; 2009 Aug; 13(4):310-3. PubMed ID: 19695065
[TBL] [Abstract][Full Text] [Related]
16. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.
Liu X; Jia R; Zhao J; Li Z
J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936
[TBL] [Abstract][Full Text] [Related]
17. [Amyloidosis--life threatening complication in rheumatoid arthritis patients].
Trefler J; Matyska-Piekarska E; Wagner T; Łacki JK
Wiad Lek; 2007; 60(9-10):457-61. PubMed ID: 18350722
[TBL] [Abstract][Full Text] [Related]
18. Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferences.
Fautrel B; Guillemin F; Meyer O; de Bandt M; Berthelot JM; Flipo RM; Lioté F; Maillefert JF; Wendling D; Saraux A; Combe B; Le Loët X; ; ;
Arthritis Rheum; 2009 Apr; 61(4):425-34. PubMed ID: 19333993
[TBL] [Abstract][Full Text] [Related]
19. The uses of disease activity scoring and the physician global assessment of disease activity for managing rheumatoid arthritis in rheumatology practice.
Harrington JT
J Rheumatol; 2009 May; 36(5):925-9. PubMed ID: 19369466
[TBL] [Abstract][Full Text] [Related]
20. Peripheral ulcerative keratitis after trabeculectomy in a patient with rheumatoid arthritis.
Papaconstantinou D; Georgopoulos G; Kalantzis G; Krassas A; Georgalas I
Cornea; 2009 Jan; 28(1):111-3. PubMed ID: 19092421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
